Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Calcium Pyrophosphate Deposition Disease
NCT06855433Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2026
- Primary completion
- Apr 2030
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in calcium pyrophosphate deposition disease (CPPD), sponsored by Brigham and Women's Hospital. Started Aug 2026; status: recruiting.
02
Drugs
colchicine
03
Conditions
calcium pyrophosphate deposition disease (CPPD)
Beyond the preview
Go deeper on NCT06855433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06855433.